Alumis skin disease drug meets main goal of two late-stage trials

Jan 6 (Reuters) – Alumis ‍said on Tuesday ‌its ‌experimental pill met the main ​goal ‍in ​two ​late-stage ‍studies in patients with ‍a type of ‍skin ‍disease.

(Reporting ​by ​Kamal ⁠Choudhury in ‌Bengaluru; Editing by Shailesh ⁠Kuber)